Related Experiment Video
Updated: Jun 5, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
Published on: May 2, 2013
On the crossroad between tolerance and posttransplant lymphoma.
Michael A Nalesnik1, Thomas E Starzl
1Thomas E. Starzl Transplantation Institute and Department of Pathology, University of Pittsburgh Medical Center, E1549 Biomedical Science Tower, 200 Lothrop Street, Pittsburgh, PA 15213, USA.
Epstein-Barr virus is linked to post-transplant lymphomas, but other factors are involved. Host-donor immune interactions, or microchimerism, may create a lymphomagenic environment, contributing to lymphoma development in transplant patients.
Area of Science:
- Immunology
- Oncology
- Transplantation
Background:
- Epstein-Barr virus (EBV) is a known factor in post-transplant lymphomas.
- However, the absence of EBV in some cases suggests other cofactors are involved in lymphomagenesis.
- Transplantation involves complex immune interactions between host and donor.
Purpose of the Study:
- To explore the role of immunologic interactions beyond Epstein-Barr virus in post-transplant lymphoma development.
- To investigate how the introduction of immunocompetent donor cells contributes to a lymphomagenic environment.
- To highlight host-donor immunologic microchimerism as a potential factor in post-transplant lymphomas.
Main Methods:
- Review of existing literature on Epstein-Barr virus and post-transplant lymphomas.
- Discussion of murine models of lymphoma following allogeneic hematopoietic cell transfer.
- Analysis of contemporary viewpoints in transplantation immunology.
Main Results:
- Not all post-transplant lymphomas are EBV-associated.
- Immunologic interactions from donor cells can create a lymphomagenic environment.
- Murine models provide insights into transplant-related lymphoma development.
Conclusions:
- Host-donor immunologic microchimerism is a potential, overlooked factor in post-transplant lymphoma pathogenesis.
- Understanding these immune dynamics is crucial for managing transplant recipients.
- Further research into non-EBV factors is warranted for comprehensive lymphoma prevention and treatment strategies.
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cell-mediated Immune Responses
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Lymphoid Cells and Tissues
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

